Magentiq Eye
PrivateLast Round
Series A
Jul 30, 2025
Total Funding Raised
$100,000
Company Overview
Magentiq Eye operates in Healthcare & Life Sciences and is based in Haifa. Its latest recorded funding round was a Series A round in July 2025.
Magentiq Eye is a medical device company that develops artificial intelligence-based software for real-time assistance during endoscopic medical procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Medical Devices, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Magentiq Eye Comparables
Compare Magentiq Eye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wision A.I. | 90% | |
| Augere Medical | 88% | |
| Iterative Health | 84% |
For institutional investors. Book with your work email.
Magentiq Eye Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 30, 2025 | ||||
| Seed | May 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Magentiq Eye Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Norgine Ventures | Series A |
| Nina Capital | Series A |
| Chaac Ventures | Seed |
| Namarel Ventures | Series A |
| aMoon | Series A |
| Nova Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2026
New versions of AI-powered colonoscopy platform now include real-time polyp detection and characterization.
- Jul 30, 2025
Led by aMoon with participation from Nova Capital and others.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withAug 26, 2026
On Aug 26th '26 in Japan, Magentiq Eye Ltd. and PENTAX Medical expand their partnership from the United States to EMEA, JAPAC, and LATAM, integrating MAGENTIQ-COLO™ into PENTAX Medical video processors and supporting its marketing, distribution, and use for AI-assisted colonoscopy.
For institutional investors. Book with your work email.
Magentiq Eye Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Magentiq Eye's valuation, stock price, and market status.
Is Magentiq Eye a public or private company?
Magentiq Eye is a private company.
What is the current stock price of Magentiq Eye?
Magentiq Eye is a private company, so its shares have no public market price. Caplight tracks Magentiq Eye's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Magentiq Eye worth (valuation)?
Valuation information for Magentiq Eye is not publicly available.
Can I buy Magentiq Eye stock?
Magentiq Eye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Magentiq Eye's last funding round?
Magentiq Eye's most recent funding round was Series A on July 30, 2025.
Who are the main investors in Magentiq Eye?
Key investors in Magentiq Eye include aMoon.
Will Magentiq Eye IPO soon?
No public IPO plans have been announced for Magentiq Eye.
How can I track Magentiq Eye secondary market activity?
Caplight tracks bids, offers, and trades in Magentiq Eye's shares on secondary markets.